德国巴登-符腾堡-黑森州红十字会献血服务中心启动研究，评估Cerus公司Intercept™血液系统处理病原体灭活血小板浓缩剂在常规临床实践中的应用

美股速递01-22

德国巴登-符腾堡-黑森州红十字会献血服务中心已正式启动一项研究项目，旨在评估采用Cerus公司Intercept™血液系统处理过的病原体灭活血小板浓缩剂在常规临床实践中的实际应用效果。该研究将重点关注该技术在临床环境下的安全性和有效性，为血液制品的病原体灭活处理提供重要的实践依据。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1154802018?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-01-22 20:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1154802018","market":"us","top_or_hot":-1,"title":"德国巴登-符腾堡-黑森州红十字会献血服务中心启动研究，评估Cerus公司Intercept™血液系统处理病原体灭活血小板浓缩剂在常规临床实践中的应用","media":"美股速递","content":"<p>德国巴登-符腾堡-黑森州红十字会献血服务中心已正式启动一项研究项目，旨在评估采用Cerus公司Intercept™血液系统处理过的病原体灭活血小板浓缩剂在常规临床实践中的实际应用效果。该研究将重点关注该技术在临床环境下的安全性和有效性，为血液制品的病原体灭活处理提供重要的实践依据。</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>德国巴登-符腾堡-黑森州红十字会献血服务中心启动研究，评估Cerus公司Intercept™血液系统处理病原体灭活血小板浓缩剂在常规临床实践中的应用</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n德国巴登-符腾堡-黑森州红十字会献血服务中心启动研究，评估Cerus公司Intercept™血液系统处理病原体灭活血小板浓缩剂在常规临床实践中的应用\n</h2>\n\n<h4 class=\"meta\">\n\n2026-01-22 20:30 北京时间&nbsp;&nbsp;&nbsp;<strong>美股速递</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>德国巴登-符腾堡-黑森州红十字会献血服务中心已正式启动一项研究项目，旨在评估采用Cerus公司Intercept™血液系统处理过的病原体灭活血小板浓缩剂在常规临床实践中的实际应用效果。该研究将重点关注该技术在临床环境下的安全性和有效性，为血液制品的病原体灭活处理提供重要的实践依据。</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4198","symbol_name":"医疗保健用品","start_time":0,"source_url":"","article_id":"1154802018","we_media_id":"1004306016","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1154802018","pubTimestamp":1769085034,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"美股速递","introduction":"全球快讯第一时间播报","home_visible":1,"id":"1004306016","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"德国巴登-符腾堡-黑森州红十字会献血服务中心已正式启动一项研究项目，旨在评估采用Cerus公司Intercept™血液系统处理过的病原体灭活血小板浓缩剂在常规临床实践中的实际应用效果。该研究将重点关注该技术在临床环境下的安全性和有效性，为血液制品的病原体灭活处理提供重要的实践依据。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4198":"医疗保健用品","CERS":"Cerus Corporation"},"translate_title":"The blood donation service of the Red Cross Society of Baden-Württemberg-Hesse, Germany, launches study to evaluate Cerus company Intercept ™ Application of pathogen-inactivated platelet concentrate in blood system treatment in routine clinical practice","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CERS":1},"content_text":"德国巴登-符腾堡-黑森州红十字会献血服务中心已正式启动一项研究项目，旨在评估采用Cerus公司Intercept™血液系统处理过的病原体灭活血小板浓缩剂在常规临床实践中的实际应用效果。该研究将重点关注该技术在临床环境下的安全性和有效性，为血液制品的病原体灭活处理提供重要的实践依据。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1154802018","isCrawlerRequest":true}